Connect with us
Eli Lilly's retatrutide cleared phase 3 targets in type 2 diabetes, cutting blood sugar and body weight, but without a head-to-head trial against tirzepatide.
Jacob Smith is in the ICU with burns after a co-worker allegedly threw hot oil on him at a Yuba City McDonald's. The suspect faces three...
A personalized mRNA vaccine kept melanoma from coming back in nearly 70% of high-risk patients five years after treatment, compared with 49% of those who received...
Adding a second hormone drug before and after prostate surgery cut the relative risk of metastasis or death by 20 percent in a 2,109-patient phase 3...